Press Releases

November 13, 2020 08:03 AM Eastern Standard Time Documentation for Payers on Cost Effectiveness of FibroScan Screening for Detecting, Monitoring Fatty Liver Disease WALTHAM, Mass.–(BUSINESS WIRE)–Echosens, a high-technology company offering…

Partnership will provide better outcomes for Medicare patients managing chronic liver diseases FORT LAUDERDALE, FLA. (PRWEB) NOVEMBER 12, 2020 ChronWell, a digital health and technology-enabled remote care management company, today announced its…

World Diabetes Day, November 14, 2020 PARIS and Waltham, MA – November 14, 2020 – Echosens, a high-technology company offering the FibroScan® family of products, recognizes the importance of World Diabetes Day…

Joint American Academy of Dermatology & National Psoriasis Foundation New Care Guidelines for Medication Management of Psoriasis Waltham, MA – August 12, 2020 – press release Echosens, a high-technology company…

JUNE 12, 2020: COLLABORATION, BEST PRACTICES AND EARLY DETECTION OF FATTY LIVER DISEASE June 8th, 2020, Published in Business Wire Echosens, a high-technology company offering the FibroScan family of products, joins…

Echosens urges increased vigilance around liver health during May 2020 Hepatitis Awareness Month and calls attention to the millions of Americans from all walks of life who are living with the most common causes of viral hepatitis: hepatitis B virus (HBV) and hepatitis C virus (HCV).

Expanding Patient-Centered Care for Chronic Liver Conditions: Gastroenterology Specialists Improve Outcomes, Lower Costs & Enhance Practice Performance March 31, 2020, Published in Business Wire Echosens, proudly announces its collaboration with…

Echosens shares a mission with the Fatty Liver Foundation to reach into every community in America to ensure asymptomatic individuals receive the screening and care they need.